Aprea Therapeutics Inc (APRE) financials · $10.4M cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Aprea Therapeutics Inc (APRE) $10.4M cap.
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Income | -$13.2M | -$14.3M |
| Net Income | -$12.6M | -$13.0M |
| EPS (Diluted) | -$1.93 | -$2.45 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $15.9M | $24.0M |
| Current Assets | $15.6M | N/A |
| Cash & Equivalents | $14.6M | $22.8M |
| PP&E | $59.8K | N/A |
| Total Liabilities | $3.49M† | N/A |
| Current Liabilities | $2.76M | N/A |
| Shareholders' Equity | $12.4M | N/A |
| Retained Earnings | -$333.6M | N/A |
† Total Liabilities: Derived: total assets minus shareholders’ equity (stored total liabilities equalled total assets, i.e. the liabilities-and-equity total).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$12.9M | -$13.6M |
| CapEx | N/A | $15.5K |
| Investing Cash Flow | N/A | -$15.5K |
| Financing Cash Flow | $4.64M | $14.8M |
| Free Cash Flow | N/A | -$13.6M |
FAQ
What is APRE P/E and revenue?
Aprea Therapeutics Inc (APRE) $10.4M cap.
What is APRE revenue?
APRE income-statement cache has no revenue figure yet.
Is APRE profitable?
Aprea Therapeutics Inc last cached net income is -$12.6M (FY2025).
What are APRE total assets?
Aprea Therapeutics Inc last cached total assets are $15.9M (FY2025).
What is APRE free cash flow?
No cached cash-flow row for APRE yet.
Not investment advice. Cached statements, not a live tape.